Lataa...
Determination of the Residues in the Extracellular Domain of the Nicotinic α Subunit Required for the Actions of Physostigmine on Neuronal Nicotinic Receptors
Physostigmine can potentiate and inhibit neuronal nicotinic receptors, in addition to inhibiting the activity of acetylcholinesterase. We found that receptors containing three copies of the α2 subunit are inhibited by low concentrations of physostigmine in contrast to receptors containing three copi...
Tallennettuna:
| Julkaisussa: | Mol Pharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548365/ https://ncbi.nlm.nih.gov/pubmed/28630263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.117.108894 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|